Full benefits are typically observed after a few months
Working with a nutritionist reduces side effect severity by 40%
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
In addition, GLP-1 can reduce liver cholesterol accumulation by inhibiting SREBP2 and PCSK9, and reduce liver bile acid synthesis by weakening the negative feedback inhibition of bile acid after inhibiting FXR
While animal studies show promise, human clinical trials havent been completed
Yes, both Wegovy and Zepbound, as GLP-1 medications, have shown significant effectiveness in reducing both food cravings and the urge to eat emotionally